Open AccessA Phase 3, Randomized, Investigator-blinded Trial Comparing Ceftobiprole With a Standard-of-care Cephalosporin, With or Without Vancomycin, for the Treatment of Pneumonia in Pediatric Patients
Author(s) -
Miroslava Bosheva,
Rusudan Gujabidze,
Éva Károly,
Ágnes Németh,
Mikaël Saulay,
Jennifer I. Smart,
Kamal Hamed
Publication year - 2021
Publication title -
the pediatric infectious disease journal/the pediatric infectious disease journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.028
H-Index - 140
eISSN - 1532-0987
pISSN - 0891-3668
DOI - 10.1097/inf.0000000000003077
Subject(s) - medicine , cephalosporin , adverse effect , pneumonia , randomized controlled trial , confidence interval , vancomycin , ceftriaxone , ceftazidime , antibiotics , surgery , staphylococcus aureus , genetics , bacteria , microbiology and biotechnology , biology , pseudomonas aeruginosa